Orexigen rises as weight reduction drug evaluate proceeds
Shares of Orexigen Therapeutics Inc. Jumped Monday after the corporate stated a European Union evaluation of its weight reduction drug Contrave, which was once licensed within the U.S. In September, is progressing on time table. …
Nielsen admits to errors in TV dimension – Cambridge Instances
Nielsen admits to error in TV measurementCambridge TimesNEW YORK, N.Y. – The Nielsen company on Friday admitted to mistakes dating again to March in its dimension of television viewing, records that serve as the muse for billions of dollars in advertising spending for the entire broadcast trade.and extra »
